Table 1.
Demographic features and antihypertensive treatments of the patient groups.
| Group I (n = 57) | Group II (n = 62) | Group III (n = 37) | |
|---|---|---|---|
| Age (years) | 53.1 ± 10 | 55.1 ± 9 | 53.0 ± 10 |
| Male sex (n (%)) | 23 (40) | 25 (40) | 15 (40) |
| BMI (kg/m2) | 27.9 ± 5.1 | 28.4 ± 4.7 | 26.5 ± 4.2 |
| DHT (> 10 years), (n (%)) | 32 (56) | 62 (100) | – |
| ACE i./ARB, (n (%)) | 54 (95) | 58 (94) | – |
| CCB, (n (%)) | 43 (75) | 49 (79) | – |
| Diuretics, (n (%)) | 32 (56) | 38 (61) | – |
| Beta blockers, (n (%)) | 19 (33) | 25 (40) | – |
BMI: body mass index, DHT: duration of hypertension, ACE i.: angiotensin converting enzyme inhibitors ARB: angiotensin receptor blockers, CCB: calcium channel blockers.